Key Sessions
Antonio Lanzavecchia, M.D
Mechanisms of Antibody-mediated Resistance to Infectious Diseases
National Institute of Molecular Genetics
June 9 - Live Sessionskeyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
June 9 - Live Sessions - BST (British Summer Time, GMT+1)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
June 9 - Live Sessions - BST (British Summer Time, GMT+1)
search
Streams
Formats
June 9 - Live Sessions 09:45 - 10:1530 mins
Scientific Briefing
June 9 - Live Sessions 10:30 - 11:0030 mins
Scientific Briefing
Are Unvalidated Antibodies Undermining Your Research?
- Monique Seymour - Scientific Sales Executive, Rapid Novor
June 9 - Live Sessions 11:15 - 12:1560 mins
Keynote Presentation with Introduction by Session Chair
Mechanisms of Antibody-mediated Resistance to Infectious Diseases
- Antonio Lanzavecchia, M.D - Invernizzi Fellow, Human Immunology Program, National Institute of Molecular Genetics
To prepare for this discussion/Q&A, attendees should watch the On-Demand presentations from speakers in this session in advance. These on-demand talks will be available for viewing starting June 1.
June 9 - Live Sessions 12:30 - 13:1545 mins
Live Panel Discussion & Speaker Q&A
Advances in T-Cell Engaging Therapies
- Kerry Chester, PhD - Professor of Molecular Medicine, UCL Cancer Institute
- Christian Klein, PhD - Head Oncology Programs, Roche Innovation Center Zurich
- Roeland Lameris, M.D. - Resident Internal Medicine and PhD Student, Amsterdam UMC
- Paul Hughes, Ph.D. - Scientific Director, Amgen
- Nadine van Montfoort , Ph.D. - Assistant Professor and Group Leader, Leiden University Medical Centre
- Stephen Russell, M.D., Ph.D. - Professor of Molecular Medicine, Mayo Clinic
- Gernot Stuhler, MD - Immunotherapy Lab, University Hospital Würzburg
June 9 - Live Sessions 14:15 - 14:4530 mins
Scientific Briefing
Uncovering Critical Receptors and Assessing Target Specificity of Biotherapeutics
- Diogo Rodrigues Ferreirinha - European Business Development Manager, Retrogenix Limited
June 9 - Live Sessions 15:00 - 15:3030 mins
Scientific Briefing
Amplifying Antibody Diversity with Single-cell Screening and Immune Repertoire Sequencing
- Kevin Heyries, Ph.D. - Co-founder & Head of Business Development, AbCellera
To prepare for this discussion/Q&A, attendees should watch the On-Demand presentations from speakers in this session in advance. These on-demand talks will be available for viewing starting June 1.
June 9 - Live Sessions 15:45 - 16:3045 mins
Live Panel Discussion & Speaker Q&A
Payloaded Antibodies and Immune-oncology – Crossroads
- Esther Breij, PhD - Senior Director, Translational Research, Genmab BV
- Francesca Zammarchi, PhD - Head of Pharmacology, ADC Therapeutics
- Sara Mangsbo, PhD - Senior Associate Lecturer, Uppsala University
- Betsy Gray, Ph.D. - Senior Scientist, Immunology, Seagen
- Myriam Fabre, Ph.D. - R&D Director, Oncomatryx Biopharma S.L.
- Michael Alonso, Ph.D. - Vice President, Immunology and Pharmacology, Bolt Biotherapeutics
Get the latest news.
As it happens
Sign up to get the latest on the agenda and speakers.
Filter
Streams
Formats
Choose Day
- Pre-Conf Training Course - Intro to Antibody Engineering - June 1-3Pre-Conf Training Course - Intro to Antibody Engineering - June 1-3
- June 8 - Live SessionsJune 8 - Live Sessions
- June 9 - Live SessionsJune 9 - Live Sessions
- June 10 - Live SessionsJune 10 - Live Sessions
- Post-Conf Training Course - Intro to Bioconjugates & ADCs - June 15-17Post-Conf Training Course - Intro to Bioconjugates & ADCs - June 15-17
- ON-DEMAND, Pre-Recorded Speaker PresentationsON-DEMAND, Pre-Recorded Speaker Presentations
- Download Agenda